RETATRUTIDE
30 mg
Read the report sample and lot scope; confirm the inventory lot separately.
A certificate of analysis describes a specific tested sample. Read the original document, identify who supplied it, and keep each measurement within its stated scope.
Compare the product name, stated strength, sample or lot code, report date and laboratory. A different strength or lot is not automatically a match to current inventory.
Identity addresses what the tested sample is. Purity reports a result under a stated analytical method. Measured content addresses quantity. One measurement does not substitute for the others.
Supplier-provided documents and independently commissioned Black Hat reports are labeled separately on the Testing page. Keep the original report intact and read any missing fields or limitations.
A report for one sample does not establish results for every vial, a future lot, or a different strength. Purity alone does not establish sterility, safety, or suitability for human or veterinary use.
Open the product listing and compare it with the original reports. Missing exact-strength or lot documentation is a gap to identify, not a result to infer.
30 mg
Read the report sample and lot scope; confirm the inventory lot separately.
30 mg
Read the report sample and lot scope; confirm the inventory lot separately.
10 mg
Read the report sample and lot scope; confirm the inventory lot separately.
80 mg
Read the report sample and lot scope; confirm the inventory lot separately.
10 mg
Exact-strength documentation remains pending; no specific COA is implied.